Study to Evaluate the Safety of Twice Daily Oral Carvedilol
Public ClinicalTrials.gov record NCT00129363. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open Label Extension Study to Evaluate the Safety of Twice Daily Oral Carvedilol in Pediatric Patients With Chronic Heart Failure
Study identification
- NCT ID
- NCT00129363
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Shaddy, Robert, M.D.
- Individual
- Enrollment
- 75 participants
Conditions and interventions
Conditions
Interventions
- Carvedilol Drug
Drug
Eligibility (public fields only)
- Age range
- 1 Day to 17 Years
- Sex
- All
- Healthy volunteers
- Not listed
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 31, 2001
- Primary completion
- Dec 31, 2005
- Completion
- Dec 31, 2005
- Last update posted
- Dec 24, 2008
2002 – 2006
United States locations
- U.S. sites
- 17
- U.S. states
- 13
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mattel Children's Hospital at UCLA | Los Angeles | California | 90025 | — |
| Children's Hospital Los Angeles | Los Angeles | California | 90027 | — |
| Stanford University | Palo Alto | California | 94303 | — |
| University of Colorado | Denver | Colorado | 80218 | — |
| University of Miami | Miami | Florida | 33101 | — |
| Children's Memorial Hospital | Chicago | Illinois | 60614 | — |
| Children's Hospital, Boston | Boston | Massachusetts | 02115 | — |
| C.S. Mott Children's Hospital | Ann Arbor | Michigan | 48109 | — |
| Children's Hospital of Michigan | Detroit | Michigan | 48201-2196 | — |
| Washington University | St Louis | Missouri | 63110-1014 | — |
| Columbia University | New York | New York | 10032-1537 | — |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | — |
| Vanderbilt Children's Hospital | Nashville | Tennessee | 37332 | — |
| UT Southwestern Medical Center | Dallas | Texas | 75235-7794 | — |
| Texas Children's Hospital | Houston | Texas | 77030 | — |
| University of Utah | Salt Lake City | Utah | 84132 | — |
| Seattle Childrens Hospital and Regional Medical Center | Seattle | Washington | 98105 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00129363, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 24, 2008 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00129363 live on ClinicalTrials.gov.